[{"Assets_0_Q2_USD":480149000.0,"CommonStockSharesOutstanding_0_Q2_shares":27044527.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-31616000.0,"NetIncomeLoss_1_Q2_USD":-23962000.0,"NetIncomeLoss_2_Q2_USD":-46040000.0,"StockholdersEquity_0_Q2_USD":448421000.0,"Ticker":"ANAB","CIK":"1370053","name":"ANAPTYSBIO, INC","OfficialName":"AnaptysBio Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"617648593.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190808"}]